These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Procollagen-III peptide and chronic viral C hepatitis. Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165 [TBL] [Abstract][Full Text] [Related]
4. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value. Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528 [TBL] [Abstract][Full Text] [Related]
5. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies]. Pagani A; Pranzo A; Sala N; Galante T Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873 [TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169 [TBL] [Abstract][Full Text] [Related]
7. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity]. García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469 [TBL] [Abstract][Full Text] [Related]
8. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen. Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813 [TBL] [Abstract][Full Text] [Related]
9. [Procollagen III and laminin in chronic viral hepatopathies]. Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303 [TBL] [Abstract][Full Text] [Related]
11. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon]. Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370 [TBL] [Abstract][Full Text] [Related]
12. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B]. Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682 [TBL] [Abstract][Full Text] [Related]
13. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease. Leonardi S; La Spina M; La Rosa M; Schilirò G Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737 [TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171 [TBL] [Abstract][Full Text] [Related]
16. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease. Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver]. Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314 [TBL] [Abstract][Full Text] [Related]
18. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915 [TBL] [Abstract][Full Text] [Related]
19. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases]. Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637 [TBL] [Abstract][Full Text] [Related]
20. [The significance of aminoterminal procollagen type-III peptide in chronic hepatopathies]. Caballería J Med Clin (Barc); 1992 May; 99(1):21-3. PubMed ID: 1602894 [No Abstract] [Full Text] [Related] [Next] [New Search]